Journal article

Review article: defining remission in ulcerative colitis

SPL Travis, PDR Higgins, T Orchard, CJ Van der Woude, R Panaccione, A Bitton, C O'Morain, J Panes, A Sturm, W Reinisch, MA Kamm, G D'Haens

Alimentary Pharmacology and Therapeutics | WILEY | Published : 2011

Grants

Funding Acknowledgements

Declaration of personal interests: Alain Bitton has served as a speaker for Axcan, as a speaker, consultant and an advisory board member for Abbott Laboratories, Merc and Shire and has received research funding from Abbott Laboratories and Merck. Geert D'Haens has served as a speaker, a consultant and an advisory board member for Abbott, Centocor, Falk, Ferring, MSD, Shire and UCB. Michael Kamm has served as a speaker, consultant, or advisory board member for Abbott, Ferring, Schering-Plough and Shire. He has received research funding from Abbott. He is an employee of St Vincent's Hospital and University of Melbourne. He owns no stock and no relevant patents. Professor Colm O'Morain is on the International Advisory Board of Abbott, Schering Plough, and Shire Pharmaceutical companies. He has unrestricted educational grants from Abbott and Schering Plough. Remo Panaccione has served as a speaker, consultant or advisory board member for Abbott Laboratories, Ferring, Merck, Shire and Warner Chilcott. He has received research funding from Abbott Laboratories and Merck. Julian Pane's has served as a speaker, consultant or advisory board member for Abbott Laboratories, Merck, Pfizer and Shire. He has received research funding from Abbott Laboratories and Schering-Plough. Walter Reinisch has served as a speaker, consultant or advisory board member for Abbott, Aesca, Astra Zeneca, Biogen, Centocor, Ferring, Elan, Essex, Genentech, MSD, Millenium, Novartis, Pharmacosmos, Schering-Plough, Shire, UCB and Vifor. Andreas Sturm has served as a speaker, consultant, or advisory board member for Falk, Shire, Ferring, Abbott Laboratories, Merck and Vifor. He has received research funding from Abbott Laboratories and Fresenius. Simon Travis has served as a speaker, consultant or advisory board member for Abbott Laboratories, Asahi, Falk, Ferring, Genentech, Glenmark, Merck, Novartis, Schering-Plough, Shire, Tillotts, UCB Pharma, Vertex, Vifor and Warner Chilcott. He has received research funding from Abbott Laboratories, Asahi, Merck. Novartis, Schering-Plough, SigmoidPharma, Vifor and Warner Chilcott. He owns no stock or relevant patents. C. Janneke van der Woude has served as a speaker, consultant, or advisory board member for Abbott Laboratories, Ferring, Merck and Shire. She has received research funding from Abbott Laboratories and Merck. Declaration of funding interests: None.